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Abstract
Alzheimer’s disease (AD) brain reveals high rates of oxygen
consumption and oxidative stress, altered antioxidant de-
fences, increased oxidized polyunsaturated fatty acids, and
elevated transition metal ions. Mitochondrial dysfunction in AD
is perhaps relevant to these observations, as such may con-
tribute to neurodegenerative cell death through the formation
of reactive oxygen species (ROS) and the release of mole-
cules that initiate programmed cell death pathways. In this
study, we analyzed the effects of beta-amyloid peptide (Ab) on
human teratocarcinoma (NT2) cells expressing endogenous
mitochondrial DNA (mtDNA), mtDNA from AD subjects (AD
cybrids), and mtDNA from age-matched control subjects
(control cybrids). In addition to finding reduced cytochrome
oxidase activity, elevated ROS, and reduced ATP levels in the
AD cybrids, when these cell lines were exposed to Ab 1–40
we observed excessive mitochondrial membrane potential
depolarization, increased cytoplasmic cytochrome c, and
elevated caspase-3 activity. When exposed to Ab, events
associated with programmed cell death are activated in AD
NT2 cybrids to a greater extent than they are in control cybrids
or the native NT2 cell line, suggesting a role for mtDNA-
derived mitochondrial dysfunction in AD degeneration.
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Excessive accumulation of cortical ‘plaques’ is a key
histopathologic feature of Alzheimer’s disease (AD).
b-Amyloid peptide (Ab), the major component of senile
plaques, is believed by some to play an important role in AD
pathogenesis (Selkoe 1990; Smith 1998). Although it is not
conclusively known how Ab toxicity (if any) might be
mediated in vivo, in vitro studies reveal Ab peptides can
cause cell demize by inducing oxidative stress (Beal 1995;
Mark et al. 1996). Whereas it is not possible to conclude Ab
is etiologically responsible, considerable data do indicate
oxidative stress occurs in AD. This is reflected by an increase
in lipid and protein oxidation markers (Smith et al. 1991;
Lovell et al. 1995).
Mitochondrial dysfunction is also observed in AD. The
activity of several different mitochondrial enzymes appears
reduced; the best studied and perhaps most important of these
enzyme defects involves cytochrome oxidase, the activity of
which is deficient in both degenerating and non-degenerating
AD tissues (Swerdlow and Kish 2002). As oxygen
radicals are a by-product of mitochondrial respiration, and
mitochondrial dysfunction can cause an increase in radical
production, these organelles may represent a relevant initi-
ating or intermediate site for increased AD oxidative stress.
Studies in our laboratory and others (Mark et al. 1996;
Cardoso et al. 2001) found Ab 25–35 and 1–40 peptides
decrease the activity of mitochondrial respiratory chain
complexes. Other studies, however, indicate Ab is not
prerequisite for mitochondrial dysfunction in AD (Swerdlow
et al. 1997; Sheehan et al. 1997; Cassarino et al. 1998;
Ghosh et al. 1999; Khan et al. 2000; Trimmer et al. 2000),
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and that mitochondrial dysfunction can increase Ab levels
(Khan et al. 2000), perhaps through altering the processing
of its parent amyloid precursor protein molecule (Gabuzda
et al. 1994). As links between Ab and mitochondrial
dysfunction appear to exist, the possibility of a positive
toxic feedback loop requires consideration.
Further data implicating an association between Ab and
mitochondrial dysfunction derive from studies of apoptosis.
Mitochondria are key players in an ‘intrinsic’ apoptosis
pathway that may be particularly relevant to AD neuro-
degeneration. In in vitro studies, Ab renders cells vulnerable
to apoptosis and activates several caspase enzymes (Naka-
gawa et al. 2000; Troy et al. 2000; Allen et al. 2001; Xu
et al. 2001; Cardoso et al. 2002).
To address the relevance and potential causes of the AD
cytochrome oxidase defect, the cytoplasmic hybrid (‘cybrid’)
technique, first described by King and Attardi (1989), has
previously been applied. In this technique, mitochondria/
mitochondrial DNA (mtDNA) from human AD and control
platelets are transferred to culturable cells depleted of
endogenous mtDNA (q0 cells). The resulting cybrids allow
for the in vitro elucidation of mitochondrial differences.
Using neuronal-like q0 nuclear backgrounds, Swerdlow
et al. (1997) found that compared to control cybrids, AD
cybrid cytochrome oxidase activity was depressed and
reactive oxygen species (ROS) formation increased. Subse-
quently, a number of investigations using AD cybrids have
revealed a number of downstream consequences of the
transferred cytochrome oxidase defect (Swerdlow et al.
1997; Sheehan et al. 1997; Cassarino et al. 1998; Ghosh
et al. 1999; Khan et al. 2000; Trimmer et al. 2000), although
one very small AD cybrid study in which a cervical
carcinoma nuclear background was used failed to show a
cytochrome oxidase defect (Ito et al. 1999).
We now report the use of cybrid cell lines to examine the
functional consequences of cytochrome oxidase dysfunction
when cells are challenged with Ab 1–40 peptide. We
observed that alterations in AD cybrid oxidative status
renders these cells vulnerable to Ab-induced cell death
because these cells manifest an excessive decrease in the
mitochondrial membrane potential (Dwm), excessive mitoch-
ondrial release of cytochrome c, and caspase enzyme
activation. Our results support the view that at least under
in vitro conditions, the adverse consequences of a primary
mitochondrial respiratory chain defect and Ab peptide can be
synergistic.
Materials and methods
Study sample includes six patients, ages from 56 to 80 years, with
probable Alzheimer’s disease (AD), evaluated at the Neurological
Unit of the University Hospital of Coimbra. Of this group, three cases
(50%) had pre-senile dementia, with onset of illness before 65 years
of age, and two had a positive family history of AD. The diagnosis of
dementia was based on the guidelines of the Diagnostic and
Statistical Manual of Mental Disorders – DSM-IV and the diagnosis
of probable AD was established according to the criteria of the
National Institute of Neurological and Communicative Disorders and
Stroke-Alzheimer’s Disease and Related Disorders Association
(NINCDS-ADRDA) (McKhann et al. 1994). All patients underwent
extensive clinical evaluation including neurological/psychiatric
examination, neuropsychological testing, and specific staging scales
which provide objective information about severity of dementia in
various domains: cognitive impairment was quantified using the
Minimental-State Evaluation (MMSE) (Foltein et al. 1975) and the
mean score of the patient group was 9.3 ± 5.4 (range 2–15). Global
dementia severity was staged as moderate (four cases) and severe
(two cases) in accordance with the Clinical Dementia Rating (CDR)
(Berg 1988). Routine laboratory tests, including chemistry profile,
complete blood count (CBC), thyroid function tests, vitamin B12 and
folic acid level, syphilis and Lyme serology were also performed, as
well as EEG, brain CT, CSF analysis and ApoE genotyping. This
evaluation confirmed the probable diagnosis of AD and allowed
further genetic classification. The genotype in this group was apo E4/
3 (two patients), two patients were homozygotic for the apo E *4
allele and another one for the apo E *3 allele. Age-matched control
subjects were free of any neurodegenerative disease, and the mean
age was (n ¼ 5) 60.67 ± 3.3 years. Phlebotomy was performed to
obtain blood samples, platelets isolated via centrifugation, and cybrid
cell lines successfully created.
Chemicals
b-Amyloid peptide fragment (Ab 1–40 or Ab 1–42) was obtained
from Bachem (Bubendorf, Germany). Fetal calf serum was obtained
from Biochrom KG (Berlin, Germany). Rhodamine 123, Mito-
Tracker-Green, MitoTracker-Red, Prolong Antifade Kit, Alexafluor
594 and 488 goat anti-mouse IgG conjugate, and Vybrant Apoptosis
assay Kit #2 were purchased from Molecular Probes (Leiden,
Netherlands). Anti-cytochrome c antibody was purchase from
PharMingen (San Diego, CA, USA). N-acetyl-Asp-6lu-val-Asp-P-
milnoanilid (DEVD-pNA) and N-acetyl-Val-6lu-Jb-Asp-P-mitnua-
milide (VEID-pNA) were from Calbiochem (Darmstadt, Germany).
All other reagents were from Sigma Chemical Co. (St. Louis, MO,
USA) or from Merck kgaA (Darmstadt, Germany).
Cell culture
Stock cultures of NT2 (human teratocarcinoma) q+ cells were
purchased from Stratagene (La Jolla, CA, USA). mtDNA-deficient
q0 cells, derived from the human NT2 teratocarcinoma line, were
obtained as a generous gift from Professor W. D. Parker laboratory.
The q0 cells have no detectable complex I or cytochrome c oxidase
activity; they are autotrophic for pyruvate (Miller et al. 1996). q0
cells were repopulated with platelet mitochondria from either control
or AD patients through fusion in the presence of polyethylene glycol
(Swerdlow et al. 1997). Untransformed cells were killed through
withdrawal of pyruvate from the culture medium (Miller et al. 1996;
Swerdlow et al. 1996). The surviving cells were termed mitoch-
ondrial cybrids (i.e. cytoplasmic hybrids). Cells were grown
routinely in 75 cm2 tissue culture flasks in Optimen Medium that
was supplemented with 10% heat inactivated fetal calf serum,
penicillin (50 U/mL), and streptomycin (50 lg/mL). NT2, control
and AD cybrids cell lines were grown and maintained at 37C in a
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humidified incubator containing 95% air and 5% CO2. Cells were
plated at 0.6 · 106/mL for ATP measurements, for reactive oxygen
species determinations, and carbonyl groups quantification,
0.15 · 106/mL for membrane potential determinations, imunocyto-
chemistry experiments and for apoptosis kit assay, and 2 · 106/mL
for determination of cytochrome c oxidase activity, citrate synthase
activity, for caspase activity and thiobarbituric acid-reactive sub-
stances (TBARS) quantification.
Twenty-four hours after seeding of cells the medium was
aspirated and replaced with similar medium containing Ab 1–40
(1 lM) peptide. Aged Ab 1–40 was added from a 230 lM stock
phosphate-buffered saline solution after incubation during 7 days at
37C. For all conditions tested, control experiments were performed
in which Ab was not added; all other incubation parameters were
unchanged.
Cytochrome c oxidase (complex IV) assay
Complex IV activity was measured according to the method of
Wharton and Tzagoloff (1967) by measuring the decrease in
absorbance at 550 nm that occurs as reduced cytochrome c is
oxidized. Cytochrome c reduction was initially performed by adding
ascorbate crystals to cytochrome c and placing the mixture in a
dialysis membrane for 18–24 h against 0.01 M phosphate buffer,
pH 7.0, at 4C. Reduced cytochrome c concentration was then
determined with 0.1 M ferricyanide. The reaction mixture contained
0.01 M potassium phosphate, pH 7.0, and 50 lM reduced cyto-
chrome c. The reaction was initiated by the addition of the
mitochondrial sample at 30C. The pseudo first order rate constant
(K) was calculated, because the reaction is of first order with respect
to cytochrome c. Results are expressed as K/(min mg of protein).
Citrate synthase assay
Citrate synthase activity was determined by the method of Coore
et al. (1971), which spectrophotometrically follows the formation of
5-thio-2-nitrobenzoate (412 nm). The reaction mixture contained
100 mM Tris, pH 8.0, 200 lM [5,5¢-dithiobis(2-mitnobentoic acid)]
(DTNB), 0.1% (v/v) Triton X-100, and the mitochondrial sample.
The assay was initiated by the addition of 100 lM oxaloacetate at
30C. Results are expressed as percentage of control cybrids.
Analysis of adenine nucleotides
After the incubation period, the medium was removed. Cells were
extracted, on ice, with 0.3 M perchloric acid. The adenine
nucleotides (ATP, ADP, and AMP) were assayed by separation in
a reverse-phase HPLC, as described by Stocchi et al. (1985). The
chromatographic apparatus used was a Beckman System Gold,
consisting of a 126 Binary Pump Model and a 166 Variable UV
detector controlled by computer. The column was a Lichrospher 100
RP-18 (5 lm) from Merck (Germany). An isocratic elution with
100 mM KH2PO4 buffer at pH 7.4 and 1% methanol was performed
at a flow rat of 1.2 mL/min. The adenine nucleotides were detected
at 254 nm for 6 min.
Monitorization of reactive oxygen species generation
ROS were measured according to Bass et al. (1983), following
the oxidation of 2¢,7¢-dichlorodihydrofluorescein (DCFH2-DA) to
fluorescent dichlorofluorescein (DCF), which detects the forma-
tion of intracellular peroxides. Cells were loaded, in the dark,
with 5 lM DCFH2-DA for 20 min in a Na
+-medium containing:
132 mM NaCl, 1 mM KCL, 1 mM MgCl2, 10 mM glucose, 10 mM
Hepes-Tris, pH 7.4, at 30C. After washing, DCF basal fluores-
cence was measured during 5 min in the same medium and H2O2
(10 lM and 100 lM) was added and measured for 5 min. DCF
fluorescence was detected with excitation and emission wave
lengths of 502 nm and 550 nm, respectively.
Quantification of lipid peroxidation
The extent of lipid peroxidation was determined by measuring
TBARS, which include malondialdehyde, using the Thiobarbituric
Acid Test according to a modified procedure described by Ernster
and Nordenbrand 1967). The amount of TBARS formed was
calculated using a molar extinction coefficient of
1.56 · 105 M)1 cm)1 and expressed as nmol TBARS/mg of protein.
Protein oxidation determination
Protein carbonyl content was determined as described by Levine
et al. 1990), with slight modifications. Cell extracts were incubated
with 0.5 mL of 10 mM dinitrophenylhydrazine in 2 N HCl (or 2 N
HCl alone for the blanks), for 1 h at room temperature. The protein
hydrazone derivatives were precipitated with 0.5 mL of 20%
trichloroacetic acid and the precipitates were washed three times
with 1 mL ethanol : ethylacetate (1 : 1). During each washing, the
homogenized pellet was vortexed and left in the washing solution
for 10 min at room temperature before centrifugation. The final
pellet was resuspended in 6 M guanidine HCl, and incubated during
15 min at 37C. The carbonyl content was determined spectro-
photometrically at 360 nm on the basis of molar absorbance
coefficient of 22 000 M)1 cm)1, and expressed as nmol/mg of
protein.
Visualization of mitochondrial membrane potential (Dw) by
confocal microscopy
After treatment, cells grown on chambered coverglasses were
washed twice with phosphate-buffered saline and incubated with
MitoTracker Red (750 nM) for 1 h, at 37C. Following a further
wash with phosphate-buffered saline, cells were fixed with 4%
formaldehyde for 15 min at room temperature. Cells were then
washed with phosphate-buffered saline and incubated with glycine
20 mM in phosphate-buffered saline. Cells were gently washed with
phosphate-buffered saline and permeabilized with saponine 0.1% in
phosphate-buffered saline for 30 min. Cells were then incubated
with anti-cytochrome c against its native form (dilution 1 : 100 in
saponine solution) for 1 h at room temperature, in the dark. Excess
antibody was removed by washing cells with saponine solution. The
secondary antibody, Alexa Fluo 488-conjugated goat anti-mouse
IgG, diluted 1 : 60 in saponine solution was added, and the cells
were incubated for 30 min at room temperature. The coverslips were
washed with saponine solution, and fixed with Antifade. Results
were obtained by confocal microscopy (Biorad MRC 600 with laser,
argon and krypton).
Visualization of cytochrome c and mitochondria by confocal
microscopy
After treatment, cells grown on chambered coverglasses were
washed twice with phosphate-buffered saline and incubated with
MitoTracker Green (750 nM) for 1 h, at 37C. Following a further
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wash with phosphate-buffered saline, cells were fixed with 4%
formaldehyde for 15 min at room temperature. Cells were then
washed with phosphate-buffered saline and incubated with glycine
20 mM in phosphate-buffered saline. Cells were gently washed with
phosphate-buffered saline and permeabilized with saponine 0.1% in
phosphate-buffered saline for 30 min. Cells were then incubated
with anti-cytochrome c against its native form (dilution 1 : 100 in
saponine solution) for 1 h at room temperature, in the dark. Excess
antibody was removed by washing cells with saponine solution. The
secondary antibody, Alexa Fluo 594-conjugated goat anti-mouse
IgG, diluted 1 : 60 in saponine solution was added, and the cells
were incubated for 30 min at room temperature. The coverslips were
washed with saponine solution, and fixed with Antifade. Results
were obtained by confocal microscopy (Biorad MRC 600 with laser,
argon and krypton).
Caspase activation assays
After treatment with Ab 1–40 (1 lM), cells were harvested for
assays of caspase activity, by the method described by Cregan et al.
(1999) with slight modifications. Cells were washed twice in
phosphate-buffered saline and collected in a buffer containing
25 mM HEPES, pH 7.5, 1 mM EDTA, 1 mM EGTA, 2 mM MgCl2,
2 mM dithiothreitol, 0.1 mM phenylmethylsulfonyl fluoride and
1 : 100 dilution of a protease inhibitor cocktail. Cells were scraped,
homogenized on ice, and frozen three times on liquid nitrogen. The
lysate was centrifuged at 15 800 g for 10 min, and the resulting
supernatant was stored at )80C. Lysates (50 lg of protein) were
incubated at 37C, during 90 min, in 25 mM HEPES, pH 7.5,
containing 0.1% CHAPS, 10% sucrose, 10 mM dithiothreitol, and
40 lM DEVD-pNA or 40 lM VEID-pNA to determine caspase 3 or
caspase 6 activation, respectively. Substrate cleavage was detected
in a Ph L Mediators Luminometer (Vienna, Austria) at 405 nm.
Externalization of phosphatydilserine by confocal microscopy
After treatment, cells grown on chambered coverglass were washed
twice with phosphate-buffered saline and incubated with 100 lL of
a solution containing the annexin V conjugate, propidium iodide in a
binding buffer, prepared according to manufacturer’s instructions.
Following a further wash with phosphate-buffered saline, cells were
mounted onto slides and observed using a confocal microscope
(Biorad MRC 600 with laser, argon and krypton).
Data analysis
Data were expressed as mean ± SEM of the indicated number of
determinations, from at least three independent experiments.
Statistical significance analysis was determined using the two-tailed
Student’s t-test (a p-value < 0.05 was considered significant).
Results
Mitochondrial respiratory chain in AD and control
cybrids
Cytochrome c oxidase activity and ATP levels were evalu-
ated in native NT2 cells, AD cybrids, and control cybrids to
determine whether the alteration observed in AD platelets
was maintained in AD cybrids (Cardoso et al. 2004). We
found that cytochrome c oxidase activity was decreased in
AD cybrids [3.15 ± 0.66 K/(min mg)] as compared to con-
trol cybrids [4.06 ± 0.57 K/(min mg)] and NT2 cells
[3.95 ± 1.02 K/(min mg)] (Fig. 1). We also evaluated citrate
synthase activity in order to abolish potential differences in
mitochondrial enrichment between AD and control cybrids.
As shown in Fig. 2, citrate synthase activity was comparable
between groups (100 ± 6.9% in controls cybrids and
88.22 ± 4.7% in AD cybrids). The ratio between cytochrome
c oxidase and citrate synthase activities in AD cybrids was
decreased as compared to control cybrids (data not shown).
Differences in mitochondrial mass are therefore unlikely to
account for the observed decrease in complex IV activity.
We further observed that this complex IV defect was
associated with decreased ATP levels in AD cybrids
(66.65 ± 5.32 nmol/mg for AD cybrids, as compared to
92.82 ± 8.06 nmol/mg in control cybrids and 91.48 ±
10.18 nmol/mg in the native NT2 cell line) (Table 1).
However, the bioenergetic state of AD cybrids cells
was not compromised, since under basal conditions mtDNA
from AD patients had a minimal impact on cellular energy
stores.
Fig. 1 Cytochrome c oxidase activity: influence of AD mtDNA. NT2 q+
cells, control and AD cybrids were used to determine cytochrome c
oxidase activity, measured spectrophotometrically as described in
Materials and Methods. Data are expressed as K/(min mg of protein),
with the mean ± SEM derived from three to four independent deter-
minations. *p < 0.05, significantly different as compared to control
cybrids.
Fig. 2 Citrate synthase activity in platelet mitochondria. Data repre-
sent the mean ± SEM of five independent experiments and are
expressed as percentage relatively to control cybrids.
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ROS production, lipid and protein oxidation in AD
cybrids
As shown in Fig. 3(a), ROS production (measured by DCF
fluorescence) in AD cybrids, was greater than that of control
cybrids (84.5 ± 9.45 K and 37.5 ± 4.88 K, respectively).
This observation is in accordance with our previous obser-
vations in AD platelets (Cardoso et al. 2004). We assessed
whether this increase in ROS induced lipid and protein
oxidation. AD cybrids showed evidence of both elevated
lipid peroxidation (1.075 ± 0.109 nmol/mg in AD cybrids,
0.610 ± 0.022 nmol/mg in control cybrids, and 0.606 ±
0.020 nmol/mg in native NT2 cells) (Table 2) and protein
carbonyl formation (7.126 ± 0.79 nmol/mg in AD cybrids,
4.400 ± 0.38 nmol/mg in control cybrids) (Fig. 3b). These
findings are consistent with previous studies showing
increased lipid and protein oxidation in AD brain tissue
(Mecocci et al. 1994; Markesbery 1997).
Effects of mtDNA background and Ab 1–40 on Dwm,
cytochrome c release, caspase activity, and
phosphatidylserine externalization
The disruption of mitochondrial membrane potential (Dwm)
appears to occur in cells undergoing apoptosis by allowing
the release of cytochrome c (Cardoso et al. 2002). As shown
in Fig. 4(a), Dwm, detected using MitoTracker-red that
accumulates in active mitochondria, decreased upon Ab 1–
40 exposure in NT2 and in cybrids, although the drop of Dwm
was more pronounced in AD cybrids. In addition, decreased
co-localization of cytochrome c with mitochondria, marked
with Green-green, was observed upon Ab 1–40 exposure in
NT2 and cybrid cells (Fig. 4b). Once more, the release of
cytochrome c from mitochondria was more marked in AD
cybrids.
In many apoptotic systems, mitochondrial release of
cytochrome c to the cytosol activates a proteolytic cascade,
namely caspase-3. To determine whether caspase-3 activation
was induced by Ab 1–40 or by Ab 1–42 we analyzed the
cleavage of the peptide substrate DEVD-pNA. As shown in
Fig. 4(c), both peptides induced caspase-3 activation in NT2
cells (2.28-fold increase and 2.13-fold increase, respect-
ively), control cybrids (2.89-fold increase and 2.28-fold
increase, respectively) and AD cybrids (2.7-fold increase and
1.82-fold increase, respectively). Nevertheless, caspase-3
activation was increased in AD cybrids in the absence of Ab
peptides (1.88-fold increase). Ab 1–40 and Ab 1–42
exposure induced an activation of caspase-6 in NT2 cells
and in AD cybrids (Fig. 4d). However, no activation of
caspase-6 was detected in control cybrids treated with Ab
(1–40 and 1–42) (Fig. 4d). When the brood range caspase
(a)
(b)
Fig. 3 The mtDNA-derived cytochrome c oxidase defect leads to
increased oxidative stress. (a) ROS formation was detected using
DCFH2-DA oxidation and fluorescence as described in Materials and
Methods. Results were expressed as the slope (k) obtained during
20 min, with the mean ± SEM derived from four to 10 independent
experiments. **p < 0.01, significantly different as compared with con-
trol cybrids. (b) Protein oxidation was determined by detecting car-
bonyl groups formation as described in Materials and Methods.
Results were expressed as nmol carbonyl groups per mg of protein,
with the mean ± SEM derived from four to five independent experi-
ments. **p < 0.01, significantly different as compared with control
cybrids.
Table 1 ATP levels and energy charge
ATP levels
(nmol/mg)
Energy
charge
NT2 cells 91.48 ± 10.18 0.90 ± 0.02
Control cybrids 92.82 ± 8.06 0.95 ± 0.03
AD cybrids 66.65 ± 5.32* 0.91 ± 0.04
The results are the means ± SEM of duplicate determinations in five
to six different experiments. *p < 0.05, significantly different as
compared to control cybrids.
Table 2 Thiobarbituric acid-reactive substances (TBARS) levels
NT2 cells (nmol/mg) 0.606 ± 0.020
Control cybrids (nmol/mg) 0.610 ± 0.022
AD cybrids (nmol/mg) 1.075 ± 0.109**
The results are the means ± SEM of duplicate determinations in five to
10 different experiments. ** p < 0.01, significantly different as com-
pared to control cybrids.
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inhibitor, ZVAD-fmk, was added simultaneously we
observed that caspase 3 and caspase 6 were not activated
(data not shown).
Phosphatidylserine (PS) is normally located on the plasma
membrane cytoplasmic surface. However, in apoptotic cells
PS translocates from the inner to the outer membrane leaflet.
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Annexin V, a Ca2+-dependent phospholipid binding protein
has a high affinity for PS. Using fluorophore-labeled annexin
V, we found that Ab 1–40 increased PS externalization in
AD cybrids more so than it did in control cybrids and NT2
cells (25% in AD cybrids, 15% in control cybrids and 6% in
NT2 cells) (Figs 5a–d). In the later stages of apoptosis,
plasma membrane compromise allows for internalization of
the nucleic acid binding dye propidium iodide (PI). PI
staining for AD and control cybrid cell lines was generally
greater than it was in the native NT2 line (12% in AD
cybrids, 6% in control cybrids and 3% in NT2 cells)
(Figs 5a–d).
Discussion
These data confirm and extend the previous finding that
expression of AD subject mtDNA within the context of the
neuronal-like NT2 nuclear background has multiple func-
tional consequences (Swerdlow et al. 1997). Mitochondrial
function in these AD cybrids is altered in ways that
recapitulate pathology observed in AD brain itself (reduced
cytochrome c oxidase activity, increased oxidative stress)
and in ways that promote events associated with pro-
grammed cell death. Our data support the view that
functionally relevant mtDNA mutation exists in AD cybrids
and by extension AD subjects, and at least partly accounts
for the cytochrome c oxidase defect that is observed in
multiple AD tissues.
It was previously proposed that the AD cytochrome c
oxidase defect constitutes a genetically determined free
radical generator (Swerdlow et al. 1997). Consistent with
this, we observed ROS formation in AD cybrids was greater
than it was in age-matched control cybrids. Additionally,
Swerdlow et al. (1997) showed that ROS production was
increased in AD cybrids despite the fact that ROS scavenging
enzymes were up regulated, probably as a compensatory
response. Dykens (1994) demonstrated that increased ROS
production in isolated cerebral mitochondria from autopic
AD brain could result from elevated basal cytosolic calcium
levels. Further, data from SH-SY5Y cells show a correlation
between cytochrome c oxidase inhibition and ROS formation
(Miller et al. 1996). Functional interactions between mitoch-
ondrial function, calcium homeostasis, and ROS formation
are potentially associated, and an imbalance of one of these
parameters may have serious consequences at a cellular level
(Beal 1992). Finally, we observed increased lipid and protein
oxidation in AD cybrids, which likely reflects increased ROS
Fig. 4 Mitochondrial function upon Ab treatment. (a) Mitochondria
membrane potential was detected by MitoTracker-red and cytochrome
c (green) co-localization, using confocal microscopy as described in
Materials and Methods. Results show a representative experiment
from three independent analyses. (b) Mitochondrial cytochrome c
retention was detected by MitoTracker-green and cytochrome c (red)
co-localization, using confocal microscopy as described in Materials
and Methods, and shows a representative experiment from three
independent analyses. (c) Caspase-3 activation was determined by
Ac-DEVD-pNA cleavage. Results were expressed relative to the basal
activity observed in the untreated cells. *p < 0.05, **p < 0.01,
***p < 0.001 vs. untreated NT2 cells. (d) Caspase-6 activation was
determined by Ac-VEID-pNA cleavage. Results were expressed rel-
ative to the basal activity observed in the untreated cells. **p < 0.01,
vs. untreated NT2 cells.
(a)
(b)
(c)
(d)
Fig. 5 Effect of Ab 1–40 on phosphatidylserine externalization.
Phosphatidylserine externalization (green) and propidium iodide
internalization (red) in (a) NT2 cells, (b) control cybrids, (c) AD cybrids,
and (d) representative graph, was determined using confocal micr-
oscopy as described in Materials and Methods. Results are repre-
sentative of three independent analyses.
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production in these cell lines. Based on the results of this
study, we propose that in AD, ROS production could
represent an important gain-of-function consequence of an
mtDNA-derived cytochrome c oxidase defect.
Cytochrome c translocates from mitochondria to the
cytosol when sufficient Dwm dissipation occurs (Mignotte
and Vayssiere 1998). It is believed that defective
mitochondria with reduced membrane potential may con-
tribute to apoptosis by releasing cytochrome c (Liu et al.
1996). Once released, cytochrome c binds Apaf-1, and in the
presence of dATP, activates caspase-9 (Zou et al. 1999). This
in turn activates a series of downstream effector caspases,
namely caspase-3 and -6 (Fernandes-Alnemri et al. 1995).
In this study we evaluated whether the cytochrome c
oxidase defect and consequent ROS overproduction observed
in AD cybrids increased susceptibility to further toxic insults.
It has been shown that mitochondrial dysfunction can
increase Ab peptide secretion. Khan et al. (2000), using
SH-SY5Y cell nuclear background, found AD cybrids
secrete twice as much Ab (1–40 and 1–42) as control cybrid
lines, have increased intracellular Ab 1–40, and develop
distinct congo red-positive Ab deposits that are not seen in
control cybrid lines. In other tissue culture models, it was
shown that cytochrome c oxidase inhibition shifts amyloid
precursor protein degradation to a potentially insoluble form
(Gabuzda et al. 1994).
Although we did not find NT2 AD cybrid cell lines to be
overly sensitive to Ab 1–40 in terms of viability measured by
MTT reduction test (data not shown), we did find Dwm was
reduced in our AD cybrids. This has been reported previ-
ously in studies using SH-SY5YAD cybrids (Cassarino et al.
1998; Khan et al. 2000). Because Dwm depolarization is
associated with mitochondrial cytochrome c release, we used
our cell lines to analyze cytochrome c co-localization with
mitochondria in the presence and absence of Ab. Compared
to control cybrids and native NT2 cells, Ab 1–40 reduced
cytochrome c-mitochondrial co-localization in AD cybrids.
Under unstressed conditions, mitochondrial cytochrome
c levels were decreased in NT2 AD cybrids, similar to the
finding of Khan et al. (2000), a study in which SH-SY5YAD
cybrid cell lines were evaluated.
To study how Ab 1–40 and Ab 1–42 affected apoptotic
induction in the cell lines under study, we evaluated caspase
enzymes whose activation is dependent (caspase-3 and -6) of
mitochondrial cytochrome c release. Both peptides activated
caspase-3 in all cell lines, and the basal activity of this
enzyme was also increased in AD cybrids. This observation
is consistent with that of Khan et al. (2000) in studies of SH-
SY5Y AD and control cybrid cell line caspase-3 activity.
Caspase-6 activity was also increased in NT2 cells and AD
cybrids with Ab treatment. Nevertheless, a reduced sensitiv-
ity for Ab peptides induced caspase-6 activity was observed
in control cybrids. Moreover, the basal caspase-6 activity was
increased in control and in AD cybrids.
To address the premise that cells with mitochondrial
impairment might be vulnerable to Ab-mediated apoptosis
induction, we used PS externalization and PI internalization
as experimental endpoints. With Ab 1–40 exposure, PS
externalization was observed in NT2 cells but this was not
accompanied by PI internalization. In both AD and control
cybrid cell lines, however, both PS externalization and PI
nuclear staining occurred, suggesting these cells entered a
more advanced apoptotic stage in which there was plasma
membrane compromise. Ab 1–40 is more toxic to cells with
mtDNA alterations, even if these alterations arise as part of
aging and are not temporally associated with AD phenotype
manifestation. Still, both PS externalization and PI internal-
ization were greater in AD than in control cybrids, after Ab
treatment, suggesting along with our cytochrome c oxidase
data that if somatic mtDNA mutations do accumulate with
age, these mutations are either quantitatively or qualitatively
different between individuals with and without an AD
phenotype.
We conclude that in AD cybrids there is a cytochrome c
oxidase defect that derives from mtDNA, gives rise to
oxidative stress, and activates pathways that are associated
with cell death. Our results indicate that the cellular
consequences of an increase in ROS production, lipid and
protein oxidation, observed in untreated AD cybrids, renders
them more vulnerable to an apoptotic cell death. While our
data do not directly address the issue of neuronal demize in
AD brain, expression of mtDNA from a non-degenerating
AD subject tissue (platelets) is associated with events that are
believed to intimately relate to neuronal loss and perhaps
neurodegeneration (Agid 1995). As AD cybrids allow
investigators to model (i) mitochondrial defects that are
observed in AD subjects, and (ii) various processes that are
associated with programmed cell death, it is worth consid-
ering the use of these cell lines for the elucidation of AD
pathophysiology and potential therapeutic interventions.
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